...
首页> 外文期刊>Crystal growth & design >Investigation of the Polymorphic Transformation of the Active Pharmaceutical Ingredient Clopidogrel Bisulfate Using the Ionic Liquid AEImBF(4)
【24h】

Investigation of the Polymorphic Transformation of the Active Pharmaceutical Ingredient Clopidogrel Bisulfate Using the Ionic Liquid AEImBF(4)

机译:离子液体AEImBF(4)研究活性药物成分硫酸氢氯吡格雷的多态转化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Since ionic liquids (ILs), salts with a melting point below 100 degrees C, have unique physicochemical properties, they have been spotlighted as novel alternatives to organic solvents. However, studies relating to polymorph control using IL as solvent have not yet been performed due to the numerous (10(18)) available IL types with unknown effects on the control of polymorphic transformation, and the extremely high unit price compared with conventional organic solvents. Presently, the pharmaceutical industry highly prefers the high soluble form-I polymorph among several polymorphs of the active pharmaceutical ingredients (APIs), clopidogrel bisulfate (CLP). However, as form-I polymorphs are metastable crystals, their phase transformation to stable form-II crystals occurs only within 5 min in the organic solvent. Therefore, the present study was performed in order to control the phenomenon that induces the rapid phase transformation from form-I to form-II. Ethanol was used as solvent, ILs including 1-allyl-3-ethylimidazolium tetrafluoroborate (AEImBF(4)), 1-butyl-2,3-dimethylimidazolium tetrafluoroborate (BDMImBF(4)), and 1,3-diallylimidazolium tetrafluoroborate (AAImBF(4)) were used as antisolvents, and drowning-out crystallization was the method applied. Among three ILs used in this experiment, only AEImBF(4) could induce crystals precipitation. Therefore, AEImBF(4) was used as antisolvent for further studies. The thermodynamic factor, the temperature, was set in the range of 25 to 50 degrees C; then the phase transformation phenomenon from form-I to form-II under temperature variation was studied. In order to illustrate the quantitative analysis of the polymorphic transformation under the new IL solvent, the nucleation and mass transfer equations were used.
机译:由于离子液体(ILs),熔点低于100摄氏度的盐具有独特的物理化学性质,因此它们已成为有机溶剂的新型替代品而备受关注。但是,由于有多种(10(18))可用的IL类型对多态转化的控制效果未知,并且与传统有机溶剂相比单价极高,因此尚未进行有关使用IL作为溶剂的多晶型控制的研究。 。当前,制药工业在活性药物成分(API)的几种多晶型物氯吡格雷硫酸氢盐(CLP)的多晶型物中高度优选I型多晶型物。但是,由于I型多晶型物是亚稳晶体,因此它们在有机溶剂中仅在5分钟内发生相转变为稳定的II型晶体。因此,进行本研究是为了控制引起从形式I到形式II的快速相变的现象。乙醇用作溶剂,ILs包括1-烯丙基-3-乙基咪唑四氟硼酸酯(AEImBF(4)),1-丁基-2,3-二甲基咪唑四氟硼酸酯(BDMImBF(4))和1,3-二烯丙基咪唑四氟硼酸酯(AAImBF( 4))用作抗溶剂,淹没结晶是所采用的方法。在此实验中使用的三个IL中,只有AEImBF(4)可以诱导晶体沉淀。因此,AEImBF(4)被用作进一步研究的抗溶剂。热力学因子温度设定在25至50摄氏度的范围内。然后研究了温度变化下从I型到II型的相变现象。为了说明在新的IL溶剂下对多晶型转变的定量分析,使用了成核和传质方程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号